Only two of the cell lines in our breast cancer panel (HBL100 and MCF7) were wild-type for TP53[26] (http://p53.free.fr/), and therefore we did not assess the correlation between p53 status and asymmetric segregation of template DNA in this study. The gene discussed is TP53; the disease is breast carcinoma.